LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability
Cellular Signalling · 2023
DOI: 10.1016/j.cellsig.2023.110839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Xu Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; Department of Urology, Guizhou Provincial People…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, RNA, Long Noncoding, RNA-Binding Proteins, RNA Stability. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The long non-coding RNA (lncRNA) AGAP2-AS1 was implicated in tumorigenesis, yet with unclear mechanism in the development of Bladder Cancer (BCa). METHODS: We collected the clinicopathological features and tissue samples of 45 patients with BCa in Xiangya Hospital. Expressions of AGAP2-AS1 and LRG1 were detected by RT-qPCR in BCa tissues and normal tissues as well as in BCa cells. The roles of AGAP2-AS1 and LRG1 were investigated by CCK-8, colony formation assay, transwell assays and tube formation assay. The subcellular localization of AGAP2-AS1 was detected by Fluorescence in situ hybridization. Bioinformatics method, RNA immunoprecipitation, RNA pull-down assay and Actinomycin D test were used to predict and identify the relationships between AGAP2-AS1, LRG1 and IGF2BP2. Xenografted tumors were produced to explore the function of AGAP2-AS1 in BCa in vivo. RESULTS: AGAP2-AS1 and LRG1 were highly upregulated in BCa. AGAP2-AS1 positively correlated with T stage, grade and vascular invasion, but negatively correlated with the survival of patients. Overexpressions of AGAP2-AS1 promoted proliferation, migration, invasion, tumor angiogenesis in vitro and tumor growth, metastasis in vivo, knockdown of AGAP2-AS1 exhibited the opposite effects. AGAP2-AS1 localized mainly in the cytoplasm. AGAP2-AS1 directly bound to IGF2BP2 protein to enhance LRG1 mRNA stability. Inhibition of BCa progression by AGAP2-AS1 knockdown may be reversed by LRG1 overexpression. CONCLUSION: AGAP2-AS1 can promote BCa progression and metastasis by recruiting IGF2BP2 to stabilize LRG1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; Department of Urology, Guizhou Provincial People's Hospital, Guiyang 550001, Guizhou, PR China.
- Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008…
- Department of Urology, Hunan Aerospace Hospital, Changsha 410008, Hunan, PR China.
- Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China.
- Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 4…
Zitieren
APA
Zhao, X., Chen, J., Zhang, C., Xie, G., Othmane, B., Kuang, X., & Liu, B. (2023). LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110839
Vancouver
Zhao X, Chen J, Zhang C, Xie G, Othmane B, Kuang X, et al. LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110839
BibTeX
@article{Zhao2023,
author = {Zhao, Xu and Chen, Jinbo and Zhang, Chunyu and Xie, Guoou and Othmane, Belaydi and Kuang, Xiaogen and Liu, Bolong},
title = {LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability},
journal = {Cellular Signalling},
year = {2023},
doi = {10.1016/j.cellsig.2023.110839}
}
EUVIMED